Reactions 1680, p49 - 2 Dec 2017 Drug induced hepatitis: case report In a retrospective study, a 22-year-old woman developed drug induced hepatitis following treatment with isoniazid, rifampicin [rifampin], pyrazinamide and ethambutol (HRZE regimen) [dosages, routes, outcome and time to reaction onset not stated]. The woman presented with history of abdominal pain. She had intestinal obstruction. Mantoux skin test was positive. Fine needle aspiration revealed granuloma of the lymph nodes. Based on these findings, a probable diagnosis of tuberculosis was made. CT scan revealed tubercular abdominal cocoon (sclerosing encapsulating peritonitis). She started receiving anti-tubercular therapy (ATT) with isoniazid, rifampin, pyrazinamide and ethambutol. She developed hepatitis induced by ATT. She received treatment with ATT for 6 months. The woman’s anti-tubercular therapy was changed to levofloxacin, streptomycin and ethambutol. Author comment: "One patient needed modification in ATT due to dvelopment of ATT induced hepatitis." Sharma V, et al. Role of conservative management in tubercular abdominal cocoon: a case series. Infection 45: 601-606, No. 5, Oct 2017. Available from: URL: http://doi.org/10.1007/s15010-017-1012-5 - India 803285411 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera